John W. Moroney MD

Gynecologic Cancer

Associate Professor, Gynecologic Oncology University of Chicago Pritzker School of Medicine

880 W. Central Rd.Suite 5000Arlington Heights, IL 60005
Phone+1 847-618-3800
Fax+1 847-618-3809

Dr. Moroney is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moroney's full profile Already have an account?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2006 - 2009
National Capital ConsortiumResidency, Obstetrics and Gynecology, 2002 - 2006
Loyola University Chicago Stritch School of MedicineClass of 2002, M.D.

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 2015 - 2029
IN State Medical License 2016 - 2027
MT State Medical License 2023 - 2025
OH State Medical License 2009 - 2016
VA State Medical License 2004 - 2010
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2017

Clinical Trials

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
UNKNOWN
PHASE3
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
UNKNOWN
NA

Publications & Presentations

PubMed

1 citations
Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer.
Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Madeline Polak, Susana Campos
Gynecologic Oncology. 2025-07-01
16 citations
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resista...
Toon Van Gorp, Kathleen N Moore, Gottfried E Konecny, Alexandra Leary, Yolanda García-García
The Lancet. Oncology. 2025-04-01
4 citations
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with ...
Thomas J Herzog, John B Liao, Karen Finkelstein, Lyndsay Willmott, Wei Duan
Gynecologic Oncology. 2025-03-01

Press Mentions

ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
30 Cancer Symptoms You Should Never IgnoreOctober 31st, 2019
Accelerating Progress in Ovarian CancerAugust 16th, 2019